FDA approves brain imaging agent
The FDA has approved an amino acid positron emission tomography drug for brain cancer imaging. The drug — called Pixclara — differentiates recurrent or progressive glioma from treatment-related tissue changes, according to a Sept. 14 news release from the drugmaker, Telix.  Pixclara is approved for use in adults and pediatric patients 1 month and older, […] The post FDA approves brain imaging agent appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.